NCT04100837

Brief Summary

To determine the Effect of multiple instrumentation regarding bacterial contamination in transportal and transtibial techniques in ACL reconstruction .A Randomized controlled study

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
80

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jan 2020

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 14, 2019

Completed
10 days until next milestone

First Posted

Study publicly available on registry

September 24, 2019

Completed
4 months until next milestone

Study Start

First participant enrolled

January 15, 2020

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 30, 2021

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 30, 2022

Completed
Last Updated

July 13, 2022

Status Verified

July 1, 2022

Enrollment Period

1.7 years

First QC Date

September 14, 2019

Last Update Submit

July 11, 2022

Conditions

Outcome Measures

Primary Outcomes (1)

  • Assessment the concentration of contamination in ACL operation.

    Effect of instrumentation on contamination of the operation,swabs will be obtained intraoperative for cultures.

    Through study completion, an average of 1 year.

Study Arms (2)

transportal group

swabs will be obtained from subcutaneous tissue at antromedial portal track in transportal technique (femoral tunnel drilling) , before and after the instrumentation and femoral screw insertion, a control sample will be taken at antrolateral track in both techniques, then samples will be sended to the lab to be studied.

transtibial group

swabs will be obtained from subcutaneous tissue at antromedial portal track in transtibial technique (femoral tunnel drilling), before and after the instrumentation and femoral screw insertion, a control sample will be taken at antrolateral track in both techniques, then samples will be sended to the lab to be studied.

Eligibility Criteria

Age18 Years - 40 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Total coverage of all eligible cases will be admitted to Arthoscopic Unit within 6 months

You may qualify if:

  • Isolated ACL Injury.
  • Non deformed knee.

You may not qualify if:

  • Associated knee injury (eg. PCL).
  • Deformed knee ( eg. genu varus , genu valgus more than 4 degree )
  • patient with medical history of being immune compromized patient eg,DM

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Assiut Univeristy

Asyut, Egypt

Location

Related Publications (1)

  • Barnstable CJ, Jones EA, Bodmer WF, Bodmer JG, Arce-Gomez B, Snary D, Crumpton MJ. Genetics and serology of HL-A-linked human Ia antigens. Cold Spring Harb Symp Quant Biol. 1977;41 Pt 2:443-55. doi: 10.1101/sqb.1977.041.01.052. No abstract available.

    PMID: 70300BACKGROUND

Biospecimen

Retention: SAMPLES WITHOUT DNA

After preparation, swabs will be obtained from subcutaneous tissue at antromedial portal track in transportal technique (femoral tunnel drilling) and in transtibial technique before and after the instrumentation and femoral screw insertion, a control sample will be taken at antrolateral track in both techniques, then samples will be sended to the lab to be studied.

MeSH Terms

Conditions

Anterior Cruciate Ligament Injuries

Condition Hierarchy (Ancestors)

Knee InjuriesLeg InjuriesWounds and Injuries

Study Officials

  • Hesham HK El-kadi, professor

    Assiut University

    STUDY DIRECTOR

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
PROSPECTIVE
Target Duration
3 Days
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Orthopedics & traumatology doctor

Study Record Dates

First Submitted

September 14, 2019

First Posted

September 24, 2019

Study Start

January 15, 2020

Primary Completion

September 30, 2021

Study Completion

March 30, 2022

Last Updated

July 13, 2022

Record last verified: 2022-07

Locations